These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1899 related articles for article (PubMed ID: 21508345)

  • 41. Prostaglandins in asthma and allergic diseases.
    Peebles RS
    Pharmacol Ther; 2019 Jan; 193():1-19. PubMed ID: 30081047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alternative pathways of arachidonate metabolism: prostaglandins, thromboxane and leukotrienes.
    Johnson M; Carey F; McMillan RM
    Essays Biochem; 1983; 19():40-141. PubMed ID: 6094186
    [No Abstract]   [Full Text] [Related]  

  • 44. Molecular basis for the inhibition of prostanoid biosynthesis by nonsteroidal anti-inflammatory agents.
    Smith WL; DeWitt DL; Shimokawa T; Kraemer SA; Meade EA
    Stroke; 1990 Dec; 21(12 Suppl):IV24-8. PubMed ID: 2175460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of inflammation and COX-derived prostanoids in the effects of bradykinin on isolated rat aorta and urinary bladder.
    Erol K; Sirmagul B; Kilic FS; Yigitaslan S; Dogan AE
    Inflammation; 2012 Apr; 35(2):420-8. PubMed ID: 21537904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular mechanisms regulating prostaglandin action.
    Mitchell MD; Trautman MS
    Mol Cell Endocrinol; 1993 Jun; 93(2):C7-10. PubMed ID: 8349020
    [No Abstract]   [Full Text] [Related]  

  • 47. Cyclooxygenases in the skin: pharmacological and toxicological implications.
    Lee JL; Mukhtar H; Bickers DR; Kopelovich L; Athar M
    Toxicol Appl Pharmacol; 2003 Nov; 192(3):294-306. PubMed ID: 14575647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.
    Celotti F; Durand T
    Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):147-62. PubMed ID: 14518558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets.
    Samad TA; Sapirstein A; Woolf CJ
    Trends Mol Med; 2002 Aug; 8(8):390-6. PubMed ID: 12127725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The role of cyclooxygenase and prostaglandins in the pathogenesis of rheumatoid arthritis].
    Stańczyk J; Kowalski ML
    Pol Merkur Lekarski; 2001 Nov; 11(65):438-43. PubMed ID: 11852819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pulmonary biosynthesis and metabolism of prostaglandins and related substances.
    Eling TE; Ally AI
    Environ Health Perspect; 1984 Apr; 55():159-68. PubMed ID: 6428876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pharmacologic closure of the patent ductus arteriosus.
    Van Overmeire B; Chemtob S
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):177-84. PubMed ID: 15701582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The advent of highly selective inhibitors of cyclooxygenase--a review.
    Cryer B; Dubois A
    Prostaglandins Other Lipid Mediat; 1998 Aug; 56(5-6):341-61. PubMed ID: 9990677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR; Ayars AG; Altman MC; Henderson WR
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
    Taketo MM
    J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arachidonic acid cascade inhibitors modulate phorbol ester-induced oxidative stress in female ICR mouse skin: differential roles of 5-lipoxygenase and cyclooxygenase-2 in leukocyte infiltration and activation.
    Nakamura Y; Kozuka M; Naniwa K; Takabayashi S; Torikai K; Hayashi R; Sato T; Ohigashi H; Osawa T
    Free Radic Biol Med; 2003 Nov; 35(9):997-1007. PubMed ID: 14572603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non steroidal anti-inflammatory and anti-allergy agents.
    Kontogiorgis CA; Hadjipavlou-Litina DJ
    Curr Med Chem; 2002 Jan; 9(1):89-98. PubMed ID: 11860351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.
    Capra V; Bäck M; Barbieri SS; Camera M; Tremoli E; Rovati GE
    Med Res Rev; 2013 Mar; 33(2):364-438. PubMed ID: 22434418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
    He W; Liu CF; Huang CQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
    Fiorucci S; Meli R; Bucci M; Cirino G
    Biochem Pharmacol; 2001 Dec; 62(11):1433-8. PubMed ID: 11728379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 95.